Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Stephen L. Kopecky"'
Autor:
Kyla M. Lara‐Breitinger, Jose R. Medina Inojosa, Zhuo Li, Sarka Kunzova, Amir Lerman, Stephen L. Kopecky, Francisco Lopez‐Jimenez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 1 (2023)
Background There is a scarcity of validated rapid dietary screening tools for patient use in the clinical setting to improve health and reduce cardiovascular risk. The Healthy Eating Index (HEI) 2015 measures compliance with the 2015 to 2020 Dietary
Externí odkaz:
https://doaj.org/article/48ab3555bee948af98a1ea93e049faca
Autor:
Ohad Oren, MD, Stephen L. Kopecky, MD, Roger S. Blumenthal, MD, Bernard J. Gersh, MB, ChB, DPhil, Eric H. Yang, MD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 3, Pp 527-531 (2020)
Externí odkaz:
https://doaj.org/article/596d19f93b6e433fbc7c8a13ae62498b
Autor:
Cindy A. Kermott, MD, MPH, Darrell R. Schroeder, MS, Stephen L. Kopecky, MD, Thomas R. Behrenbeck, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 2, Pp 122-130 (2019)
Objective: To elucidate whether cardiorespiratory fitness (CRF) is protective or contributory to coronary artery disease plaque burden. Patients and Methods: Study participants were working middle-aged men from the Mayo Clinic Executive Health Progra
Externí odkaz:
https://doaj.org/article/70425ada556344a8b2383a7e6af66797
Autor:
David Harmon, MD, Tyler Schmidt, MD, Nadia Akhiyat, MD, MS, Erica Kludtke, RN, Jeffrey Meeusen, PhD, Stephen L. Kopecky, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 3, Iss , Pp 100055- (2020)
Externí odkaz:
https://doaj.org/article/7754acd247104761aca618b2bfe7a4ef
Autor:
David M. Harmon, MD, Tyler Schmidt, MD, Nadia Akhiyat, MD, MS, Erica Kludtke, RN, Stephen L. Kopecky, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 3, Iss , Pp 100062- (2020)
Externí odkaz:
https://doaj.org/article/edef595f9cff42cba33e7905af67e1ca
Autor:
Jeremy R. Van't Hof, Sue Duval, Adrienne Walts, Stephen L. Kopecky, Russell V. Luepker, Alan T. Hirsch
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 10 (2017)
BackgroundNo previous study has evaluated the impact of past US Preventive Services Task Force statements on primary prevention (PP) aspirin use in a primary care setting. The aim of this study was to evaluate temporal changes in PP aspirin use in a
Externí odkaz:
https://doaj.org/article/81d01527882545c99cfa8a857579585a
Autor:
Shawna D. Bellew, Merri L. Bremer, Stephen L. Kopecky, Christine M. Lohse, Thomas M. Munger, Paul M. Robelia, Peter A. Smars
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundAtrial fibrillation (AF) is a common, growing, and costly medical condition. We aimed to evaluate the impact of a management algorithm for symptomatic AF that used an emergency department observation unit on hospital admission rates and pat
Externí odkaz:
https://doaj.org/article/4858bf33ca2044e5882dbe00061f9a99
Autor:
Danika M. Nelson, Bo E. Madsen, Stephen L. Kopecky, Carole E. Jenson, Ann R. Loth, Aidan F. Mullan, Casey M. Clements, Grace Lin
Publikováno v:
Heart & Lung. 57:31-40
Heart Failure (HF) is a primary diagnosis for hospital admission from the Emergency Department (ED), although not all patients require hospitalization. The Emergency Heart Failure Mortality Risk Grade (EHMRG) estimates 7-day mortality in patients wit
Autor:
Holly K. Van Houten, Candace L. Jackson, Stephen L. Kopecky, Xiaoxi Yao, Nilay Shah, Yihong Deng
Publikováno v:
Journal of Clinical Lipidology. 15:339-346
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were approved in August 2015 as an adjunct to maximally tolerated statin treatment in those with familial hypercholesterolemia (FH).To assess PCSK9 inhibitor utilization patterns and ch
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA
Objective The study sought to characterize the evaluation of patients who present following detection of an abnormal pulse using Apple Watch. Materials and Methods We conducted a retrospective review of patients evaluated for abnormal pulse detected